On the recordMarch 22, 2023
By simply telling a generic drug manufacturer what adjustments they need to make, our bipartisan bill would help improve the generic market approval process and lower drug prices overall.
Source
congress.govBy simply telling a generic drug manufacturer what adjustments they need to make, our bipartisan bill would help improve the generic market approval process and lower drug prices overall.
Discusses a bill aimed at improving generic drug approval and reducing prices.
Share
More from Maggie Hassan
For too long, Big Pharma has been abusing the patent process to block generic competition and keep drug prices for patients artificially high.
This un-American plan will inevitably result in some law-abiding U.S. citizens not being able to receive the ballots they're entitled to and reduce citizen participation in our democracy.
On time delivery for first-class mail in the New Hampshire region has fallen by more than 10 percentage points over the last eight years and is now more than five percentage points below the postal service's own target of 87%.